메뉴 건너뛰기




Volumn 21, Issue 8, 1998, Pages 1288-1294

Role of orlistat in the treatment of obese patients with type 2 diabetes: A 1-year randomized double-blind study

(15)  Hollander, Priscilla A a,n   Elbein, Steven C c   Hirsch, Irl B d   Kelley, David e   McGill, Janet f   Taylor, Terry g   Weiss, Stuart R h   Crockett, Samuel E j   Kaplan, Roy A i   Comstock, John b   Lucas, Charles P k   Lodewick, Peter A l   Canovatchel, William m   Chung, Jain m   Hauptman, Jonathan m  


Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SULFONYLUREA DERIVATIVE; TETRAHYDROLIPSTATIN;

EID: 0031904104     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.8.1288     Document Type: Article
Times cited : (614)

References (32)
  • 1
    • 0027434883 scopus 로고
    • Benefits and adverse effects of weight loss: Observations from the Framingham Study
    • Higgins M, D'Agostino R, Kannel W, Cobb J, Pinsky J: Benefits and adverse effects of weight loss: observations from the Framingham Study Ann Intern Med 119:758-763, 1993
    • (1993) Ann Intern Med , vol.119 , pp. 758-763
    • Higgins, M.1    D'Agostino, R.2    Kannel, W.3    Cobb, J.4    Pinsky, J.5
  • 2
    • 0029966681 scopus 로고    scopus 로고
    • Weight and non-insulin-dependent diabetes mellitus
    • Pi-Sunyer F: Weight and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 63 (Suppl. 3):426S-429S, 1996
    • (1996) Am J Clin Nutr , vol.63 , Issue.SUPPL. 3
    • Pi-Sunyer, F.1
  • 3
    • 0028917432 scopus 로고
    • Weight gain as a risk factor for clinical diabetes mellitus in women
    • Colditz G, Willett W, Rotnitzky A, Manson J: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481-486, 1995
    • (1995) Ann Intern Med , vol.122 , pp. 481-486
    • Colditz, G.1    Willett, W.2    Rotnitzky, A.3    Manson, J.4
  • 4
    • 0027966932 scopus 로고
    • Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men
    • Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961-969, 1994
    • (1994) Diabetes Care , vol.17 , pp. 961-969
    • Chan, J.M.1    Rimm, E.B.2    Colditz, G.A.3    Stampfer, M.J.4    Willett, W.C.5
  • 6
    • 0027062816 scopus 로고
    • Abdominal fat distribution and the metabolic syndrome
    • Bjorntorp P: Abdominal fat distribution and the metabolic syndrome. J Cardiovasc Pharmacol 20 (Suppl. 8):S26-S28, 1992
    • (1992) J Cardiovasc Pharmacol , vol.20 , Issue.SUPPL. 8
    • Bjorntorp, P.1
  • 7
    • 0024587721 scopus 로고
    • Biology of regional body fat distribution: Relationship to non-insulin-dependent diabetes mellitus
    • Kissebah AH, Peiris AN: Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83-109, 1989
    • (1989) Diabetes Metab Rev , vol.5 , pp. 83-109
    • Kissebah, A.H.1    Peiris, A.N.2
  • 8
    • 0027487857 scopus 로고
    • Regional obesity and NIDDM
    • Bjorntorp P: Regional obesity and NIDDM. Adv Exp Med Biol 334:279-285, 1993
    • (1993) Adv Exp Med Biol , vol.334 , pp. 279-285
    • Bjorntorp, P.1
  • 9
    • 0027496056 scopus 로고
    • Abdominal obesity as important component of insulin-resistance syndrome
    • Despres J: Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9:452-459, 1993
    • (1993) Nutrition , vol.9 , pp. 452-459
    • Despres, J.1
  • 13
    • 0028963260 scopus 로고
    • Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years
    • United Kingdom Prospective Diabetes Study (UKPDS): 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 310:83-88, 1995
    • (1995) BMJ , vol.310 , pp. 83-88
  • 14
    • 0027482072 scopus 로고
    • Short-term medical benefits and adverse effects of weight loss
    • Pi-Sunyer F: Short-term medical benefits and adverse effects of weight loss. Ann Intern Med 119:722-726, 1993
    • (1993) Ann Intern Med , vol.119 , pp. 722-726
    • Pi-Sunyer, F.1
  • 15
    • 10544235698 scopus 로고    scopus 로고
    • Long-term pharmacotherapy in the management of obesity
    • National Task Force on the Prevention and Treatment of Obesity: Long-term pharmacotherapy in the management of obesity. JAMA 276:1907-1915, 1996
    • (1996) JAMA , vol.276 , pp. 1907-1915
  • 16
    • 0030867864 scopus 로고    scopus 로고
    • Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: A systematic review of the evidence
    • McCann U, Seiden L, Rubin L, Ricaurte G: Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: a systematic review of the evidence. JAMA 278:666-672, 1997
    • (1997) JAMA , vol.278 , pp. 666-672
    • McCann, U.1    Seiden, L.2    Rubin, L.3    Ricaurte, G.4
  • 17
    • 0028103894 scopus 로고
    • Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers
    • Zhi J, Melia A, Guerciolini R, Chung J, Kinberg J, Hauptman J, Patel I: Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 56:82-85, 1994
    • (1994) Clin Pharmacol Ther , vol.56 , pp. 82-85
    • Zhi, J.1    Melia, A.2    Guerciolini, R.3    Chung, J.4    Kinberg, J.5    Hauptman, J.6    Patel, I.7
  • 18
    • 0026604775 scopus 로고
    • Initial studies in humans with the novel gas- Trointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin)
    • Hauptman JB, Jeunet FS, Hartmann D: Initial studies in humans with the novel gas- trointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am J Clin Nutr 55 (Suppl. 1):309S-313S, 1992
    • (1992) Am J Clin Nutr , vol.55 , Issue.SUPPL. 1
    • Hauptman, J.B.1    Jeunet, F.S.2    Hartmann, D.3
  • 23
    • 0028817815 scopus 로고
    • U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes : A progressive disease
    • U.K. Prospective Diabetes Study Group: U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes : a progressive disease. Diabetes 44:1249-1258, 1995
    • (1995) Diabetes , vol.44 , pp. 1249-1258
  • 24
    • 0023925108 scopus 로고
    • Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus
    • Henry RR, Brechtel G, Griver K: Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 66:979-986, 1988
    • (1988) J Clin Endocrinol Metab , vol.66 , pp. 979-986
    • Henry, R.R.1    Brechtel, G.2    Griver, K.3
  • 26
    • 0027230221 scopus 로고
    • Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease
    • Pontiroli AE, Calderara A, Pacchioni M, Cassisa C, Pozza G: Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease. Diabete Metab 19:30-35, 1993
    • (1993) Diabete Metab , vol.19 , pp. 30-35
    • Pontiroli, A.E.1    Calderara, A.2    Pacchioni, M.3    Cassisa, C.4    Pozza, G.5
  • 27
    • 0025370045 scopus 로고
    • Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs
    • Wing RR, Shoemaker M, Marcus MD, McDermott M, Gooding W: Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs. Int J Obes 14:495-503, 1990
    • (1990) Int J Obes , vol.14 , pp. 495-503
    • Wing, R.R.1    Shoemaker, M.2    Marcus, M.D.3    McDermott, M.4    Gooding, W.5
  • 29
    • 0029044690 scopus 로고
    • Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM: A placebo-controlled dose-comparison study
    • Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB: Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM: a placebo-controlled dose-comparison study. Diabetes Care 18:817-824, 1995
    • (1995) Diabetes Care , vol.18 , pp. 817-824
    • Coniff, R.F.1    Shapiro, J.A.2    Robbins, D.3    Kleinfield, R.4    Seaton, T.B.5    Beisswenger, P.6    McGill, J.B.7
  • 30
    • 0029858649 scopus 로고    scopus 로고
    • A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
    • Lemieux S, Prudqhomme D, Bouchard C, Tremblay A, Despres J: A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 64:685-693, 1996
    • (1996) Am J Clin Nutr , vol.64 , pp. 685-693
    • Lemieux, S.1    Prudqhomme, D.2    Bouchard, C.3    Tremblay, A.4    Despres, J.5
  • 31
    • 0029689190 scopus 로고    scopus 로고
    • Reduction of visceral adipose tissue and improvement in metabolic indices: Effect of dexfenfluramine in NIDDM
    • Marks SJ, Moore NR, Clark ML, Strauss BJG, Hockaday TDR: Reduction of visceral adipose tissue and improvement in metabolic indices: effect of dexfenfluramine in NIDDM. Obes Res 4:1-8, 1996
    • (1996) Obes Res , vol.4 , pp. 1-8
    • Marks, S.J.1    Moore, N.R.2    Clark, M.L.3    Strauss, B.J.G.4    Hockaday, T.D.R.5
  • 32
    • 3543042129 scopus 로고    scopus 로고
    • FDA Pink Sheet. 9/26/96 FDA's Endocrinologic and Metabolic Drugs Advisory Committee Review of New Drug Application for Sibutramine. Washington, DC, U.S. Govt. Printing Office, Sept. 26, 1996
    • FDA Pink Sheet. 9/26/96 FDA's Endocrinologic and Metabolic Drugs Advisory Committee Review of New Drug Application for Sibutramine. Washington, DC, U.S. Govt. Printing Office, Sept. 26, 1996


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.